Phase 1 lead‐in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma - Concepedia

Concepedia

Publication | Open Access

Phase 1 lead‐in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma

DOI Full Paper Access

68

Citations

41

References

2018

Year

Stefania Maraka, Morris D. Groves, Aaron Mammoser, Isaac Melguizo‐Gavilanes, Charles A. Conrad, Ivo W. Tremont‐Lukats, Monica Loghin, Barbara O’Brien, Vinay K. Puduvalli, Erik P. Sulman,

Abstract

Memantine, mefloquine, and metformin can be combined safely with TMZ in patients with newly diagnosed glioblastoma.

References

	Year	Citations

Page 1